Prazepam
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | centraccentraxdemetrinlysanxiapozapamprasepineprazenereapamtrepidan | — | — | |
| Safety | ||||
| Dose · Oral | ||||
| Light | 5–10 mg | — | — | |
| Common | 10–20 mg | — | — | |
| Strong | 20–40 mg | — | — | |
| Duration | ||||
| Onset | 45–120 minutes | — | — | |
| Total | 8–20 hours | — | — | |
| After-effects | 8–24 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | — | GABRA1 | |
| Half-life | — | 36-200 hours | — | |
TripSit summary
Benzodiazepine dervative. Has all the normal benzodiazepine-like quality (Anxiolytic/anticonvulsant/sedative/Skeletal muscle relaxant) It is also a prodrug for Desmethyldiazepam which is responsible for most if not all of the effects of Prazepam.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.